United States · FDA National Drug Code directory
TREMFYA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57894-651_01b4ab20-c027-482f-b358-b9beae545cb3
- Product NDC
- 57894-651
- Form
- INJECTION
- Composition / generic term
- guselkumab
- Labeler
- Janssen Biotech, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20240911
- Source listing expiry
- 20271231
Source-listed ingredients
- GUSELKUMAB — 200 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (57894-651-02) / 2 mL in 1 SYRINGE (57894-651-01) · 57894-651-02
- 2 CARTON in 1 CARTON (57894-651-04) / 1 SYRINGE in 1 CARTON (57894-651-02) / 2 mL in 1 SYRINGE (57894-651-01) · 57894-651-04
- 1 SYRINGE in 1 CARTON (57894-651-22) / 2 mL in 1 SYRINGE (57894-651-11) · 57894-651-22
- 1 SYRINGE in 1 CARTON (57894-651-92) / 2 mL in 1 SYRINGE (57894-651-99) · 57894-651-92
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →